Tadenang

General characteristics. Structure:

Active agent: African plum of bark extract of 50 mg

Excipients: peanut butter — 150 mg  

Capsule cover: gelatin; glycerin; titanium dioxide; sodium salt of chlorophyllin of copper.

Pharmacological properties:

Pharmacodynamics. Has anti-proliferative effect on fibroblasts, stimulated b-FGF (major factors of growth of fibroblasts) to which the essential part in an etiology and a pathogeny of adenoma of a prostate is assigned now. Does not influence a hormonal background.

Indications to use:

Disturbances of an urination at a benign hyperplasia (adenoma) of a prostate.

Route of administration and doses:

Inside, before food, on 50 mg 2 times a day (in the morning and in the evening). A course of treatment — 6–8 weeks; if necessary carrying out repeated courses is possible.

Features of use:

In the course of treatment systematic observation of a condition of a prostate is necessary. Therapy of Tadenanom® cannot replace necessary surgical intervention.

Side effects:

From bodies of a GIT: seldom — nausea, a lock or diarrhea.
Seldom — allergic reactions.

Interaction with other medicines:

There are no data.

Contraindications:

Hypersensitivity to drug.

Overdose:

There are no data.

Storage conditions:

At a temperature not above 25 °C.
To store in the place, unavailable to children.

Issue conditions:

Without recipe

Packaging:

In the blister of 10 pieces; in a pack cardboard 1 or 3 blisters.